Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
J Clin Res Pediatr Endocrinol ; 16(1): 50-59, 2024 03 11.
Article in English | MEDLINE | ID: mdl-37750394

ABSTRACT

Objective: The postnatal activation of the hypothalamic-pituitary-gonadal (HPG) axis is usually known as "minipuberty". There are still open questions about its biological function and significance depending on sex, gestational age (GA) and birth weight (BW) with few available longitudinal data. Methods: A single-centre, longitudinal study to quantify urinary follicle stimulating hormone (uFSH), luteinizing hormone (uLH) and testosterone (uTs) in male neonates. Neonates were enrolled and stratified into three subgroups: full-term boys appropriate for GA (FT AGA); FT boys with BW ≤3rd centile [FT small for gestational age (SGA)]; and preterm (PT) boys ≤33 weeks of GA. Urinary hormones were correlated to simultaneous auxological parameters, linear growth and external genitalia at scheduled time-points. Results: Forty-six boys were recruited, with subgroup sizes FT AGA n=23, FT SGA n=11 and PT n=12. PT boys display a pulsatile pattern of urinary gonadotropins (uGns) with higher levels of uLH and a gradual increase of uTs. Testicular descent started from 29-32 weeks with the peak of uTs. During the first 12-months post-term age (PTA), FT AGA boys displayed a better linear growth (p<0.05). PT showed higher uGns levels until 3-months PTA. PT babies had higher uLH levels than FT AGA, with a peak at 7 and 30 days, during the first 90 days of life (p<0.001) and higher uTs levels. Correlation analysis between penile growth of all neonates and uTs was significant (p=0.04) but not within subgroups. Conclusion: This study investigated postnatal HPG axis activation in term and PT infants. Minipuberty may involve an early window of opportunity to evaluate the functionality of the HPG axis. Further studies with a long-term follow-up are needed with a special focus on possible consequences of GA and BW.


Subject(s)
Infant, Premature , Infant, Small for Gestational Age , Infant, Newborn , Infant , Female , Male , Humans , Gestational Age , Longitudinal Studies , Birth Weight , Fetal Growth Retardation
2.
Antibiotics (Basel) ; 11(2)2022 Feb 12.
Article in English | MEDLINE | ID: mdl-35203839

ABSTRACT

Prematurity exposes newborns to increased risks of infections and it is associated with critical morbidities. Preterm infants often require antibiotic therapies that can affect the correct establishment of gut microbiota. The aim of this study was to investigate targeted intestinal bacteria in preterm neonates with common morbidities and receiving antibiotic treatments of variable duration. Stool samples were collected after birth, at 15, 30 and 90 days of life. qPCR quantification of selected microbial groups (Bifidobacterium spp., Bacteroides fragilis group, Enterobacteriaceae, Clostridium cluster I and total bacteria) was performed and correlation between their levels, the duration of antibiotic treatment and different clinical conditions was studied. An increasing trend over time was observed for all microbial groups, especially for Bifdobacterium spp. Prolonged exposure to antibiotics in the first weeks of life affected Clostridium and B. fragilis levels, but these changes no longer persisted at 90 days of life. Variations of bacterial counts were associated with the length of hospital stay, feeding and mechanical ventilation. Late-onset sepsis and patent ductus arteriosus reduced the counts of Bifidobacterium, whereas B. fragilis was influenced by compromised respiratory conditions. This study can be a start point for the identification of microbial biomarkers associated with some common morbidities and tailored strategies for a healthy microbial development.

3.
J Matern Fetal Neonatal Med ; 34(14): 2384-2390, 2021 Jul.
Article in English | MEDLINE | ID: mdl-31488018

ABSTRACT

We describe the case of a neonate with signs of heart failure. Echocardiography showed a structural normal heart shape with left ventricular dysfunction. At 2 months of age, a vein of Galen arteriovenous malformation was diagnosed through a brain magnetic resonance imaging. Embolization therapy was accomplished and a clinical and neurological follow-up was started. This clinical case highlights how important it is considering an intracranial cause in the differential diagnosis of neonatal congestive heart failure (CHF). We performed a narrative minireview of the literature about treatments and outcome of this malformation in association to CHF, to point out how complex the diagnosis of vein of Galen aneurysmal malformation (VGAM) may be and how an early diagnosis is important for its management.


Subject(s)
Cerebral Veins , Embolization, Therapeutic , Heart Failure , Vein of Galen Malformations , Heart Failure/diagnosis , Heart Failure/etiology , Heart Failure/therapy , Humans , Infant, Newborn , Magnetic Resonance Imaging , Vein of Galen Malformations/diagnosis , Vein of Galen Malformations/diagnostic imaging
4.
J Matern Fetal Neonatal Med ; 33(6): 1036-1043, 2020 Mar.
Article in English | MEDLINE | ID: mdl-30058404

ABSTRACT

There is an increasing evidence that the intestinal microbiota plays a pivotal role in the maturation of the immune system and in the prevention of diseases occurring during the neonatal period, childhood, and adulthood. A number of nonphysiological conditions during the perinatal period (i.e. caesarean section, prolonged hospitalization, formula feeding, low gestational age) may negatively affect the normal development of the microbiota, leading to decreased amounts of lactobacilli and bifidobacteria and increased amounts of Clostridia. In addition, perinatal antibiotics can cause intestinal dysbiosis that has been associated with short- and long-term diseases. For example, prolonged early empiric antibiotics increase the risk of necrotizing enterocolitis (NEC) and late-onset sepsis (LOS) in preterm neonates, whereas the administration of intrapartum antibiotic prophylaxis (IAP) has been associated with inflammatory bowel diseases, obesity, and atopic conditions, such as eczema and wheezing. Promoting breastfeeding, reducing the length of hospital stay, and reducing unnecessary antibiotic therapies are useful strategies to counterbalance unintended effects of these conditions.


Subject(s)
Child Health , Gastrointestinal Microbiome , Infant Health , Anti-Bacterial Agents , Breast Feeding , Cesarean Section/adverse effects , Child , Child, Preschool , Dermatitis, Atopic/microbiology , Dermatitis, Atopic/prevention & control , Enterocolitis, Necrotizing/microbiology , Enterocolitis, Necrotizing/prevention & control , Gastrointestinal Microbiome/drug effects , Gastrointestinal Microbiome/immunology , Gastrointestinal Microbiome/physiology , Gestational Age , Health Promotion , Hospitalization , Humans , Infant , Infant, Newborn , Inflammatory Bowel Diseases/microbiology , Inflammatory Bowel Diseases/prevention & control , Obesity/microbiology , Obesity/prevention & control , Protective Factors , Risk Factors , Sepsis/microbiology , Sepsis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL